Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
Miller, A A
Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062). [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research May 1997 - 719-25 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
1078-0432
Administration, Oral
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics
Bone Marrow--pathology
Carcinoma, Small Cell--drug therapy
Cisplatin--administration & dosage
Disease-Free Survival
Etoposide--administration & dosage
Female
Humans
Infusions, Intravenous
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Regression Analysis
Time Factors
Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062). [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research May 1997 - 719-25 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
1078-0432
Administration, Oral
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics
Bone Marrow--pathology
Carcinoma, Small Cell--drug therapy
Cisplatin--administration & dosage
Disease-Free Survival
Etoposide--administration & dosage
Female
Humans
Infusions, Intravenous
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Regression Analysis
Time Factors